Radiolabeling procedure, quality control and stability of 99mTc-labeled chondroitin sulfate: A new approach of targeting osteoarthritis

Applied Radiation and Isotopes

Volumn 66, Issue 4, 2008, Pages 415-420

  Sobal, Grazyna ^a   Menzel, Ernst Johannes ^b   Sinzinger, Helmut ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

99mTc chondroitin sulfate; Osteoarthritis; Radiochemical purity; Radiolabeling; Radiopharmaceuticals; Stability

Indexed keywords

CARTILAGE; COLLOIDS; QUALITY CONTROL;

OSTEOARTHRITIS; RADIOCHEMICAL PURITY; RADIOLABELING PROCEDURE; RADIOPHARMACEUTICALS;

POLYSACCHARIDES;

CHONDROITIN SULFATE; TECHNETIUM 99M; TRACER;

ARTICLE; CARTILAGE; COLLOID; DIAGNOSTIC IMAGING; DRUG STABILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR STABILITY; OSTEOARTHRITIS; PH MEASUREMENT; PRIORITY JOURNAL; QUALITY CONTROL;

CHONDROITIN SULFATES; CHROMATOGRAPHY, GEL; DRUG STABILITY; HUMANS; ISOTOPE LABELING; OSTEOARTHRITIS, KNEE; QUALITY CONTROL; RADIOPHARMACEUTICALS; TECHNETIUM;

EID: 39749087101     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2007.11.002     Document Type: Article

References (19)

1. Bourgeois P., Chales G., Dehais J., Delcambre B., Kuntz J.L., and Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg per day vs. 3×400 mg per day vs. placebo. Osteoarthr. Cartilage. 6SA (1994) 25-30
2. Budinger T.F., and Taylor S.E. New approaches to targeting arthritis with radiopharmaceuticals. J. Rheumatol. Suppl. 43 (1995) 62-67
3. Camejo G., Rosengren B., Olson U., Lopez F., Olofson S.O., Westerlund C., and Bondjers G. Molecular basis of the association of arterial proteoglycans with low density lipoproteins; its effect on the structure of the lipoprotein particle. Eur. Heart J. 11 Suppl. E (1990) 164-173
4. Dawes J., and Pepper D.S. Catabolism of low-dose heparin in man. Thromb. Res. 14 (1979) 845-860
5. Dieppe P., Cushnagan J., Young P., and Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann. Rheum. Dis. 52 (1993) 557-563
6. Dietrich C.P., Martins J.R.M., Sampaio L.O., and Nader H.B. Anomalous structure of urinary chondroitin sulfate. A potential marker for diagnosis of neoplasies. Lab. Invest. 68 (1993) 439-445
7. 99mTc et scintigraphie du cartilage. Isot. Radioact. Clin. Rech. 12 (1976) 183-191
8. Hardingham T.E., and Fosang A.J. Proteoglycans, many forms, many functions. FASEB J. 6 (1992) 861-870
9. Jamar F., Manicourt D.H., Leners N., Vanden Berghe M., and Beckers C. Evaluation of disease activity in rheumatoid arthritis and other arthritides using 99mtechnetium labeled nonspecific human immunoglobulin. J. Rheumatol. 22 (1995) 850-854
10. Kaplan M., and Aviram M. Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein. Atherosclerosis 149 (2000) 5-17
11. Palmer W.E., Schoenberg O.I., Fischman A.J., Rosenthall D.I., and Polisson R.P. FDG metabolism in the wrist during treatment of inflammatory arthritis: quantitation with PET and correlation with clinical response (abstr.). J. Nucl. Med. 35 (1994) 45pp
12. Palmieri L., Conte A., Giovannini L., Lualdi P., and Ronca F. Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforsch. Drug Res. 40 (1990) 319-323
13. Ronca F., Palmieri L., Pinicucci P., and Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthr. Cartilage. 6SA (1998) 14-21
14. 125I) LDL on macrophages. J. Recept. Signal Transduct. Res. 22 (2002) 459-470
15. Sobal G., Resch U., and Sinzinger H. Modification of low-density lipoprotein by different radioiodination methods. Nucl. Med. Biol. 31 (2004) 381-388
16. Staprans I., and Felts J.M. Isolation and characterization of glycosaminoglycans in human plasma. J. Clin. Invest. 76 (1985) 1984-1991
17. Trattnig S., Ba-Ssalamah A., Puig S., and Imhof H. Magnetic resonance imaging of articular cartilage and evaluation of cartilage disease. Invest. Radiol. 35 (2000) 595-601
18. Uebelhart D., Thonar E.J.M.A., Delmas P.D., Chantraine A., and Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis. a pilot study. Osteoarthr. Cartilage. 6SA (1998) 39-46
19. Uebelhart D., Thonar E.J.M.A., Zhang J., and Williams J.M. Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit. Osteoarthr. Cartilage. 6SA (1998) 6-13